Document Detail

Oesophageal mucosal involvement in patients with systemic sclerosis receiving proton pump inhibitor therapy.
MedLine Citation:
PMID:  17206947     Owner:  NLM     Status:  MEDLINE    
AIM: To assess the prevalence of oesophagitis, Barrett's oesophagus (BE) and other oesophageal mucosal abnormalities in patients with systemic sclerosis (SSc) without prior selection on digestive clinical presentation. We also investigated the association between oesophageal endoscopic and manometric data with clinical manifestations of SSc. METHODS: Oesophageal endoscopy and manometry were performed in 133 consecutive patients with SSc, receiving proton pump inhibitor (PPI) therapy since SSc diagnosis. RESULTS: Endoscopy revealed oesophagitis in 43 patients (32.3%), BE in 9 patients (6.8%), candidiasis in 7 patients (5.3%) and hyperplastic polyp arising in ectopic gastric mucosa in 1 patient. Patients with severe oesophageal motor impairment further exhibited a higher prevalence of interstitial lung disease (ILD) when compared with those without. CONCLUSION: Our study underlines the high frequency of oesophageal mucosal abnormalities in unselected SSc patients receiving long-term PPI therapy. A relationship between oesophagitis/BE and severe manometric motor disturbances was established; these patients may require a higher regimen of PPI. Finally, our series indicates a correlation between severe oesophageal motor disturbances and evidence for ILD in patients, suggesting that gastro-oesophageal reflux may be one of the contributing factors of ILD in SSc; this subgroup of patients may require close monitoring of lung parameters.
I Marie; P Ducrotte; P Denis; M F Hellot; H Levesque
Related Documents :
1650287 - Increased prevalence of hereditary metabolic diseases among native indians in manitoba ...
3410327 - Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gas...
16538107 - The relationship between gastro-oesophageal reflux symptoms and achalasia.
11449097 - Chronic middle ear disease and gastroesophageal reflux disease: a causal relation?
12209227 - Trans-mediastinal gunshot wounds: are "stable" patients really stable?
24357597 - Post-marketing surveillance study with iodixanol in 20 185 chinese patients from routin...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Alimentary pharmacology & therapeutics     Volume:  24     ISSN:  0269-2813     ISO Abbreviation:  Aliment. Pharmacol. Ther.     Publication Date:  2006 Dec 
Date Detail:
Created Date:  2007-01-08     Completed Date:  2007-06-07     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8707234     Medline TA:  Aliment Pharmacol Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  1593-601     Citation Subset:  IM    
Department of Internal Medicine, Rouen University Hospital, Rouen Cedex, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Esophagitis / chemically induced*
Gastric Mucosa / secretion*
Gastroesophageal Reflux / chemically induced
Middle Aged
Proton Pumps / adverse effects,  antagonists & inhibitors*
Scleroderma, Systemic / drug therapy*
Reg. No./Substance:
0/Proton Pumps
Comment In:
Aliment Pharmacol Ther. 2007 Apr 1;25(7):857; author reply 858-9   [PMID:  17373925 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Use of antisecretory drugs among consumers of non-steroidal anti-inflammatory drugs in the general p...
Next Document:  An in vitro comparison of different providers to deliver four proton pump inhibitor products through...